Health Canada has informed Canadians of a possible link between Baraclude [entecavir] and the development of a treatment-resistant HIV strain

Source: Reactions Weekly, Volume 1, Number 1141, 2007-03-03 , pp. 2-2(1)

Publisher: Adis International

Keywords: Drug-resistance; Entecavir, adverse reactions; Healthcare-news; HIV-infections, drug-induced; Pharmacovigilance

Document Type: Short communication

Publication date: 2007-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers